Request Demo
Last update 31 Oct 2026
Suzhou Shengji Pharmaceutical Co Ltd
Last update 31 Oct 2026
Overview
Tags
Urogenital Diseases
Endocrinology and Metabolic Disease
Peptide Hormone
Biosimilar
CTP fusion protein
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20263521
一项评估绒促卵泡激素α N01注射液（晟诺娃®）在≥35岁进行辅助生殖技术（ART）的试验参与者中的疗效、安全性的多中心、随机、双盲、活性药平行对照的III期临床试验
[Translation] A multicenter, randomized, double-blind, parallel-controlled phase III clinical trial evaluating the efficacy and safety of human follicle-stimulating hormone alpha (Hydrogen troponin α) injection (Shengnuova®) in participants aged ≥35 years undergoing assisted reproductive technology (ART).
NCT06599528
A Phase I Clinical Trial to Compare the Pharmacokinetics, Safety and Immunogenicity of SJ04 and Ovidrel® in Healthy Female Subjects in China
CTR20201374
重组人卵泡刺激素-CTP融合蛋白注射液在进行辅助生殖技术（ART）患者中的II/III期临床试验
[Translation] Phase II/III clinical trial of recombinant human follicle-stimulating hormone-CTP fusion protein injection in patients undergoing assisted reproductive technology (ART)
100 Clinical Results associated with Suzhou Shengji Pharmaceutical Co Ltd
Login to view more data
Login to view more data
100 Deals associated with Suzhou Shengji Pharmaceutical Co Ltd
Login to view more data
100 Translational Medicine associated with Suzhou Shengji Pharmaceutical Co Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 09 Nov 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1
1
1
Approved
Other
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free